Elixinol Wellness Limited (EXL.AX)
AUD 0.02
(-10.53%)
AUD 0.02
(-10.53%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.26 Million AUD | 17.21% |
| 2022 | 7.05 Million AUD | -24.45% |
| 2021 | 9.33 Million AUD | -37.79% |
| 2020 | 15.01 Million AUD | -51.13% |
| 2019 | 30.71 Million AUD | -17.28% |
| 2018 | 37.13 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.77 Million AUD | 0.0% |
| 2023 Q2 | 3.45 Million AUD | 0.0% |
| 2023 FY | 8.26 Million AUD | 17.21% |
| 2023 Q4 | 4.81 Million AUD | 0.0% |
| 2022 Q4 | 3.83 Million AUD | 0.0% |
| 2022 Q2 | 3.21 Million AUD | 0.0% |
| 2022 FY | 7.05 Million AUD | -24.45% |
| 2021 FY | 9.33 Million AUD | -37.79% |
| 2021 Q4 | 4.54 Million AUD | 0.0% |
| 2021 Q2 | 4.79 Million AUD | 0.0% |
| 2020 Q2 | 7.85 Million AUD | 0.0% |
| 2020 FY | 15.01 Million AUD | -51.13% |
| 2020 Q4 | 7.16 Million AUD | 0.0% |
| 2019 Q2 | 17.45 Million AUD | 0.0% |
| 2019 FY | 30.71 Million AUD | -17.28% |
| 2019 Q4 | 9.72 Million AUD | 0.0% |
| 2018 Q4 | 6.79 Million AUD | 0.0% |
| 2018 Q1 | 9.28 Million AUD | 0.0% |
| 2018 FY | 37.13 Million AUD | 0.0% |
| 2018 Q2 | 14.88 Million AUD | 60.36% |
| 2017 Q4 | 9.28 Million AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Althea Group Holdings Limited | 29.4 Million AUD | 71.875% |
| Cann Group Limited | 15.37 Million AUD | 46.211% |
| ECS Botanics Holdings Ltd | 20.03 Million AUD | 58.718% |
| Ecofibre Limited | 27.98 Million AUD | 70.451% |
| Hygrovest Limited | 260 Thousand AUD | -3080.385% |
| IDT Australia Limited | 13.22 Million AUD | 37.479% |
| Invion Limited | 3.69 Million AUD | -123.834% |
| Little Green Pharma Ltd | 19.56 Million AUD | 57.742% |
| Live Verdure Ltd | 1.93 Million AUD | -327.115% |
| Medical Developments International Limited | 33.14 Million AUD | 75.055% |
| Vitura Health Limited | 123.87 Million AUD | 93.324% |
| Vita Life Sciences Limited | 74.16 Million AUD | 88.85% |